Nivolumab

Results: 11



#Item
1MEDICATION GUIDE OPDIVO® (op-DEE-voh) (nivolumab) Injection Read this Medication Guide before you start receiving OPDIVO and before each infusion. There may be new information. If your healthcare provider prescribes OPD

MEDICATION GUIDE OPDIVO® (op-DEE-voh) (nivolumab) Injection Read this Medication Guide before you start receiving OPDIVO and before each infusion. There may be new information. If your healthcare provider prescribes OPD

Add to Reading List

Source URL: packageinserts.bms.com

- Date: 2016-11-10 14:24:43
    2HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    - Date: 2015-10-01 10:48:12
      324 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

      24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

      Add to Reading List

      Source URL: www.nzma.org.nz

      Language: English - Date: 2016-05-25 01:37:50
      412 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

      12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

      Add to Reading List

      Source URL: www.nzma.org.nz

      Language: English - Date: 2016-07-11 21:31:12
      5Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha

      Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha

      Add to Reading List

      Source URL: www.kyowa-kirin.com

      Language: English - Date: 2015-07-29 19:00:03
        62015 年5月26日 各位 ブリストル・マイヤーズ スクイブ社 ニボルマブ（オプジーボ、Nivolumab BMS）に ついて治療歴を有する進行期肺扁平上皮がん患者の治療薬として E

        2015 年5月26日 各位 ブリストル・マイヤーズ スクイブ社 ニボルマブ（オプジーボ、Nivolumab BMS）に ついて治療歴を有する進行期肺扁平上皮がん患者の治療薬として E

        Add to Reading List

        Source URL: www.ono.co.jp

        Language: Japanese - Date: 2015-05-26 05:02:31
          7Horizon Scanning in Oncology Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma

          Horizon Scanning in Oncology Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma

          Add to Reading List

          Source URL: eprints.hta.lbg.ac.at

          Language: English - Date: 2015-04-08 06:15:42
            8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

            HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

            Add to Reading List

            Source URL: packageinserts.bms.com

            Language: English - Date: 2015-03-04 21:16:39
            9OPDIVO (nivolumab) injection Label

            OPDIVO (nivolumab) injection Label

            Add to Reading List

            Source URL: www.accessdata.fda.gov

            Language: English - Date: 2014-12-22 14:21:57
            10Microsoft PowerPoint - Nivolumab_PODAC_Core_FINAL.pptx

            Microsoft PowerPoint - Nivolumab_PODAC_Core_FINAL.pptx

            Add to Reading List

            Source URL: www.fda.gov

            Language: English